Implantable nanochannel delivery devices
US12151021B2 · kind B2 · utility
0Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 27, 2023 |
| Grant date | Nov 26, 2024 |
| Priority date | — |
| Expiry date | Feb 27, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M5/14276
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.